Volume 65 Received 28 October 2008 | |||||||||||
| |||||||||||
aLaboratoire de Chimie des Substances Naturelles, Faculté des Sciences Semlalia, BP 2390 Bd My Abdellah, 40000 Marrakech, Morocco,bInstituto de Química Física Rocasolano, Consejo Superior de Investigaciones Científicas, Serrano 119, 28002 Madrid, Spain,cLaboratoire de Chimie de Coordination, Unité Matériaux, Faculté des Sciences Semlalia, BP 2390 Bd My Abdellah, 40000 Marrakech, Morocco, and dLaboratoire des Sciences des Matériaux, Département de Physique, Faculté des Sciences Semlalia, BP 2390 Bd My Abdellah, 40000 Marrakech, Morocco
Correspondence e-mail: nouzha@ucam.ac.ma
The racemic title compound, a new terpenoid, C20H29N3O2S·0.5C4H8O2, was synthesized from Cedrus Atlantica essential oil. The compound crystallizes with a disordered ethyl acetate solvent molecule. The thiadiazole ring is almost planar, with a maximum deviation from the mean plane of 0.015 (2) Å for the C atom connected to the isobutyl group and has a puckering amplitude of 0.026 (2) Å. The dihedral angle between the benzene and thiadiazole rings is 18.32 (8)°. The crystal packing involves intermolecular N-H
O hydrogen bonds.
For 1,3,4-thiadiazole derivatives and their biological activity, see: Abdou et al. (1991
); Sakthivel et al. (2008
); Tehranchian et al. (2005
); Wang et al. (1999
, 2004
). For preparative methods, see: Beatriz et al., 2002
; Mohammed et al. (2008
); For puckering parameters, see: Cremer & Pople (1975
).
|
|
|
| |||||||||||||||||
Data collection: APEX2 (Bruker, 2005
); cell refinement: SAINT (Bruker, 2005
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia,1997
); software used to prepare material for publication: WinGX (Farrugia, 1999
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: FJ2168 ).
We thank Professor Jean-Claude Daran, Laboratoire de Chimie de Coordination, Toulouse, France, for his fruitful help.
Abdou, N. A., Soliman, I. N. & Sier Abou, A. H. (1991). Bull. Facpharm. (Cairo Univ.), 28, 29.
Beatriz, N. B., Albertina, G. M., Miriam, M. A., Angel, A. L., Graciela, Y. M. & Norma, B. D. (2002). Arkivok, x, 14-23.
Bruker (2005). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
![[details]](../../../../../../j/graphics/details.gif)
Mohammed, T., Mazoir, N., Daran, J.-C., Berraho, M. & Benharref, A. (2008). Acta Cryst. E64, o610-o611.
![[details]](../../../../../../e/graphics/details.gif)
Sakthivel, P., Joseph, P. S., Muthiah, P. T., Sethusankar, K. & Thennarasu, S. (2008). Acta Cryst. E64, o216.
![[details]](../../../../../../e/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Tehranchian, S., Akbarzadeh, T., Fazeli, R. M., Jamifar, H. & Shafiee, A. (2005). Bioorg. Med. Chem. Lett. 15, 1023-1025.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Wang, Y.-G., Cao, L., Yang, J., Ye, W.-F., Zhou, Q.-C. & Lu, B.-X. (1999). Chem. J. Chin. Univ. 20, 1903-1905. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Wang, Y.-G., Wang, Z. Y., Zhao, X. Y. & Song, X. J. (2004). Chin. J. Org. Chem. 24, 1606-1609. ![[ChemPort]](../../../../../../logos/chemportborder.gif)